| Dr Brittany Lynn O'neill Dulmage, MD | |
|
540 Officenter Pl Ste 240, Gahanna, OH 43230-5317 | |
| (614) 293-1707 | |
| (614) 293-1716 |
| Full Name | Dr Brittany Lynn O'neill Dulmage |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 540 Officenter Pl Ste 240, Gahanna, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588050694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35.136304 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Internal Medicine Llc | 5496651408 | 984 |
News Archive
In a normal full-term pregnancy, signals from the mature organs of the fetus and the aging placental membranes and placenta prompt the uterus' muscular walls to begin the labor and delivery process. It's still unclear how these signals accomplish this goal or how they reach from the fetal side to the maternal side.
The Barth Syndrome Foundation recently announced awardees from its 2017 grant cycle. Miriam Greenberg, Ph.D., professor of biological sciences in the College of Liberal Arts and Sciences at Wayne State University and a resident of Ann Arbor, Michigan, received a one-year, $50,000 grant for the project, "Cardiolipin activates pyruvate dehydrogenase (PDH) - a potential new target for treatment of Barth syndrome."
Not all patients with blood clots in their legs – a condition known as deep vein thrombosis – need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.
Transgenomic, Inc. announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company's CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.
Behavioral Innovations, the premier Dallas/Fort Worth provider of Applied Behavior Analysis (ABA) services for families of children with autism and other developmental disorders, announces its partnership with key insurance carriers to offer in-network insurance coverage for several ABA therapy programs. Behavioral Innovations is the first behavioral therapy center in the Metroplex to offer in-network insurance for select treatments - mitigating the financial burden on parents.
› Verified 6 days ago
| Entity Name | Osu Internal Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
In a normal full-term pregnancy, signals from the mature organs of the fetus and the aging placental membranes and placenta prompt the uterus' muscular walls to begin the labor and delivery process. It's still unclear how these signals accomplish this goal or how they reach from the fetal side to the maternal side.
The Barth Syndrome Foundation recently announced awardees from its 2017 grant cycle. Miriam Greenberg, Ph.D., professor of biological sciences in the College of Liberal Arts and Sciences at Wayne State University and a resident of Ann Arbor, Michigan, received a one-year, $50,000 grant for the project, "Cardiolipin activates pyruvate dehydrogenase (PDH) - a potential new target for treatment of Barth syndrome."
Not all patients with blood clots in their legs – a condition known as deep vein thrombosis – need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.
Transgenomic, Inc. announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company's CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.
Behavioral Innovations, the premier Dallas/Fort Worth provider of Applied Behavior Analysis (ABA) services for families of children with autism and other developmental disorders, announces its partnership with key insurance carriers to offer in-network insurance coverage for several ABA therapy programs. Behavioral Innovations is the first behavioral therapy center in the Metroplex to offer in-network insurance for select treatments - mitigating the financial burden on parents.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brittany Lynn O'neill Dulmage, MD 700 Ackerman Rd, Ste 2120, Columbus, OH 43202-1559 Ph: (614) 293-1707 | Dr Brittany Lynn O'neill Dulmage, MD 540 Officenter Pl Ste 240, Gahanna, OH 43230-5317 Ph: (614) 293-1707 |
News Archive
In a normal full-term pregnancy, signals from the mature organs of the fetus and the aging placental membranes and placenta prompt the uterus' muscular walls to begin the labor and delivery process. It's still unclear how these signals accomplish this goal or how they reach from the fetal side to the maternal side.
The Barth Syndrome Foundation recently announced awardees from its 2017 grant cycle. Miriam Greenberg, Ph.D., professor of biological sciences in the College of Liberal Arts and Sciences at Wayne State University and a resident of Ann Arbor, Michigan, received a one-year, $50,000 grant for the project, "Cardiolipin activates pyruvate dehydrogenase (PDH) - a potential new target for treatment of Barth syndrome."
Not all patients with blood clots in their legs – a condition known as deep vein thrombosis – need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.
Transgenomic, Inc. announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company's CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.
Behavioral Innovations, the premier Dallas/Fort Worth provider of Applied Behavior Analysis (ABA) services for families of children with autism and other developmental disorders, announces its partnership with key insurance carriers to offer in-network insurance coverage for several ABA therapy programs. Behavioral Innovations is the first behavioral therapy center in the Metroplex to offer in-network insurance for select treatments - mitigating the financial burden on parents.
› Verified 6 days ago
Michael Todd Mckelvey, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 925 N Hamilton Rd, Suite 100, Gahanna, OH 43230 Phone: 614-473-9519 Fax: 614-473-9543 | |
Susan C Massick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5175 Morse Rd, Suite 100, Gahanna, OH 43230 Phone: 614-293-1707 Fax: 614-293-1716 | |
Dr. Larisa Ravitskiy, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 602 Morrison Rd, Gahanna, OH 43230 Phone: 614-585-9900 Fax: 614-585-9999 | |
Joel Bain Herron, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 925 N Hamilton Rd, Suite 100, Gahanna, OH 43230 Phone: 614-473-9519 Fax: 614-473-9543 | |
Abraham Moris Korman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 540 Officenter Pl Ste 240, Gahanna, OH 43230 Phone: 614-293-1707 Fax: 614-293-1716 | |
Stephanie Saed Trovato, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 540 Officenter Pl Ste 240, Gahanna, OH 43230 Phone: 614-293-1707 Fax: 614-293-1716 | |
Catherine Ann Ulman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 540 Officenter Pl Ste 240, Gahanna, OH 43230 Phone: 614-293-1707 Fax: 614-293-1716 |